A review on the modernization of pharmaceutical development and manufacturing-Trends, perspectives, and the role of mathematical modeling

被引:56
作者
Destro, Francesco [1 ]
Barolo, Massimiliano [1 ]
机构
[1] Univ Padua, Dept Ind Engn, CAPE Lab Comp Aided Proc Engn Lab, via Marzolo 9, I-35131 Padua, PD, Italy
关键词
Pharmaceutical industry; Quality-by-design; Quality-by-control; Pharmaceutical development; Pharmaceutical manufacturing; Industry; 4; 0; Industrial digitalization; NEAR-INFRARED SPECTROSCOPY; DESIGN SPACE DETERMINATION; PROCESS FAULT-DETECTION; BY-CONTROL QBC; PREDICTIVE CONTROL; SOFT-SENSOR; CONTROL-SYSTEM; CRYSTALLIZATION PROCESSES; SENSITIVITY-ANALYSIS; PRODUCT DEVELOPMENT;
D O I
10.1016/j.ijpharm.2022.121715
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Recently, the pharmaceutical industry has been facing several challenges associated to the use of outdated development and manufacturing technologies. The return on investment on research and development has been shrinking, and, at the same time, an alarming number of shortages and recalls for quality concerns has been registered. The pharmaceutical industry has been responding to these issues through a technological moderni-zation of development and manufacturing, under the support of initiatives and activities such as quality-by-design (QbD), process analytical technology, and pharmaceutical emerging technology. In this review, we analyze this modernization trend, with emphasis on the role that mathematical modeling plays within it. We begin by outlining the main socio-economic trends of the pharmaceutical industry, and by highlighting the life-cycle stages of a pharmaceutical product in which technological modernization can help both achieve consis-tently high product quality and increase return on investment. Then, we review the historical evolution of the pharmaceutical regulatory framework, and we discuss the current state of implementation and future trends of QbD. The pharmaceutical emerging technology is reviewed afterwards, and a discussion on the evolution of QbD into the more effective quality-by-control (QbC) paradigm is presented. Further, we illustrate how mathematical modeling can support the implementation of QbD and QbC across all stages of the pharmaceutical life-cycle. In this respect, we review academic and industrial applications demonstrating the impact of mathematical modeling on three key activities within pharmaceutical development and manufacturing, namely design space description, process monitoring, and active process control. Finally, we discuss some future research opportunities on the use of mathematical modeling in industrial pharmaceutical environments.
引用
收藏
页数:26
相关论文
共 284 条
  • [1] Abboud Leila., 2003, The Wall Street Journal
  • [2] Accumulus Sinergy, 2021, 10 LEAD BIOPH COMP A
  • [3] Evaluation of mixed suspension mixed product removal crystallization processes coupled with a continuous filtration system
    Acevedo, David
    Pena, Ramon
    Yang, Yang
    Barton, Alastair
    Firth, Paul
    Nagy, Zoltan K.
    [J]. CHEMICAL ENGINEERING AND PROCESSING-PROCESS INTENSIFICATION, 2016, 108 : 212 - 219
  • [4] Addison P. S., 2017, ILLUSTRATED WAVELET
  • [5] Meta-modeling based efficient global sensitivity analysis for wastewater treatment plants - An application to the BSM2 model
    Al, Resul
    Behera, Chitta Ranjan
    Zubov, Alexandr
    Gernaey, Krist, V
    Sin, Gurkan
    [J]. COMPUTERS & CHEMICAL ENGINEERING, 2019, 127 : 233 - 246
  • [6] Am Ende M.T., 2019, CHEM ENG PHARM IND D
  • [7] [Anonymous], 2021, The pharmaceutical industry and global health: Facts and figures 2021
  • [8] [Anonymous], 2004, Pharmaceutical cGMPs for the 21st century: A risk based approach
  • [9] [Anonymous], 2022, Recalls, market withdrawals, and safety alerts
  • [10] [Anonymous], 2019, Deloitte